Forensic Evaluation of 6-Dye Chemistry Kit Composed Of 23 Loi with Casework Samples by Al Janaahi, Naeema Saleh
United Arab Emirates University 
Scholarworks@UAEU 
Biology Theses Biology 
11-2019 
Forensic Evaluation of 6-Dye Chemistry Kit Composed Of 23 Loi 
with Casework Samples 
Naeema Saleh Al Janaahi 
Follow this and additional works at: https://scholarworks.uaeu.ac.ae/bio_theses 
 Part of the Biotechnology Commons, and the Molecular Biology Commons 
Recommended Citation 
Al Janaahi, Naeema Saleh, "Forensic Evaluation of 6-Dye Chemistry Kit Composed Of 23 Loi with 
Casework Samples" (2019). Biology Theses. 20. 
https://scholarworks.uaeu.ac.ae/bio_theses/20 
This Thesis is brought to you for free and open access by the Biology at Scholarworks@UAEU. It has been 
accepted for inclusion in Biology Theses by an authorized administrator of Scholarworks@UAEU. For more 


















Copyright © 2019 Naeema Saleh Al Janaahi 













1) Advisor: Prof. Synan AbuQamar 
Title: Professor 
Department of Biology 
College of Science 
 
2) Co-advisor: Dr. Rashed Alghafri 
Title: Associate Professor 
General Department of Forensic Sciences and Criminology 








Short Tandem Repeats (STRs) are short nucleotide sequence repeats consisting of 2-8 
base pairs (bp), representing approximately 3% of human DNA. Markers of STRs have 
been widely used as genetic markers in forensic DNA analysis and have proven to be 
an extremely discriminating method for human identification in forensics. The main 
objective of this research was to evaluate a six-dye STR multiplex assay (Virifiler™ 
Plus) composed of 23 autosomal STR loci, one insertion/deletion polymorphic marker 
on the Y chromosome, Amelogenin and two internal quality control markers (IQCS 
and IQCL) using biological stains found in different crime scenes. The study 
investigated the performance of several tests, including: sensitivity, reproducibility, 
stability, heterozygote balance, precision, mixture study and concordance study. The 
results showed that the assay was reproducible, sensitive, accurate and robust. 
Sensitivity testing showed that a full profile could be obtained even with 63 pg of 
human DNA. Heterozygous allele balance varied between 60-99% for samples with 
total DNA input ranging from 1 ng-500 pg. It is also suitable for mixture studies which 
occur when the evidence contains a mixture of DNA coming from several contributors. 
All alleles of minor contributors were called for ratios of 1:1, 1:3 and 3:1. Overall, the 
current study demonstrates that this multiplex assay is robust and reliable as an assay 
for human identification with forensic casework samples, and most importantly is 
suitable to be used in Dubai Forensic Laboratory and other forensic laboratories 
worldwide. This study is the first to evaluate Virifiler™ Plus with casework samples. 
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Title and Abstract (in Arabic) 
  الجنائيةموقع جيني الستخدامها في تطبيقات األدلة  23تفعيل بصمة وراثية تتكون من 
 صالملخ
ترددات البصمة الوراثية القصيرة عبارة عن سلسلة قصيرة من القواعد تعتبر 
تشكل ما  يه و  ،قواعد نيتروجينية زوجية 8-2النيتروجينية المتكررة والتي يتراوح طولها ما بين 
الوراثية % من تكوين الحمض النووي لإلنسان. أصبحت ترددات المواقع الجينية للبصمة 3يقارب 
لكشف لنها وسيلة تمييزية أوأثبتت  .العالمة الجينية المختارة في التحليل الجنائي للعينات البيولوجية
الهدف الرئيس من هذه األطروحة هو تقييم فحص  إنعن هوية االنسان في التحاليل الجنائية. 
موقع جيني  23من  ( والتي تتكونVirifiler™ Plusترددات المواقع الجينية للبصمة الوراثية )
منتشرة على الكروموسومات الرئيسية المكونة للحمض والنووي باإلضافة الى مواقع من الحمض 
( اللذان يحددان جنس االنسان وعالمات مراقبة XYالنووي متعددة األشكال على الكروموسومين ) 
الدراسة  بحثت هذهجودة تحاليل البصمة الوراثية خاصة العينات المرفوعة من مسرح الجريمة. 
قابلية إعادة الحصول على نفس النتائج في أداء العديد من االختبارات بما في ذلك: الحساسية، 
التي تنتج من اآلثار دراسة العينات المختلطة  ، توازن الزيجوت المتغاير، الدقة،الثبات ، بالتكرار
ت الدراسة بأن هذا نه رودراسة توافق العينات. بص المحتوية على الحمض النووي لعدة أشخا
أظهرت اختبارات و هذاالفحص قابل إلعادة اإلنتاج وعلى درجة عالية من الحساسية والدقة والقوة. 
 63الحساسية انه يمكن الحصول على قراءات متكاملة من الحمض النووي باستخدام كمية 
% للعينات 99- 60بيكوغرام من الحمض النووي اآلدمي. تراوح توازن الزايجوت المتغاير بين 
 ا الفحص مناسب هذا  يعتبربيكوجرام.  500-نانوجرام 1كمية الحمض النووي فيها  نوك تالتي 
، 1:1النسب بلدراسة العينات المختلطة. حيث أن جميع أليالت المساهم الثانوي كانت مقروءة 
االنسان لتحديد هوية ودقيق أن هذا الفحص مناسب  ،وبشكل عام ،. تظهر الدراسة3:1، و 1:3
لالستخدام في المختبر الجنائي بدبي  الئمفي العينات المرفوعة من مسرح الحوادث الجنائية وم 
 ™Virifilerهذه الدراسة هي أول دراسة لتقييم ) وغيرها من المختبرات الجنائية حول العالم. 
Plus .واستخدامها لتحاليل البصمة الوراثية للعينات المرفوعة من مسرح الجريمة ) 
 
توازن الزايجوت المتغاير، عالمات مراقبة جودة  ،دراسة توافق العينات : فاهيم البحث الرئيسيةم
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Chapter 1: Introduction 
1.1 Literature Review 
Advanced molecular biological tools are universally used in DNA analysis to 
identify information contained in crime scene evidence. These advances have allowed 
scientists to provide critical information to solve crimes and the criminal justice 
community to convict the guilty and justify the innocent. Scientific research continues 
to develop new automated technologies and methods to yield more information from 
limited samples allowing scientists to optimize time and effort [1]. 
1.1.1 History of Forensic DNA  
In 1980s, forensic scientist used statistical interpretation to analyze the 
biological stains from different type of cases such as homicide and sexual assault that 
could represent only 10% of the population; Unfortunately, results were not accurate 
as it ruled out 90% of the population as a possible donor [1].  
In 1985, Alec Jefferys discovered a new method to analyze biological stains 
called DNA typing. It was found that certain regions of DNA contain specific 
sequences that are next to each other and repeated a number of times. These regions 
are known as variable number of tandem repeats (VNTR). He also proved the ability 
of these repeats to differentiate human individuals. Moreover, a technique by Jefferys 
was developed to examine the length variation of these sequence repeats called 
restriction fragment length polymorphism (RFLP) analysis. This technique uses multi 
locus probe and a restriction enzyme that cuts the region of DNA surrounding the 






Since that time, DNA typing methods has been used in human identity testing 
in forensic laboratories. Enormous growth has been seen in the use of DNA evidence 
in crime scene investigation and paternity testing. More than 150 public forensic 
laboratories and other private paternity testing laboratories are conducting thousands 
of DNA tests in the United States [2] and in other forensic laboratories around the 
world.  
1.1.2 DNA Typing Methods 
STR markers analyzed by capillary electrophoresis (CE) represent the gold-
standard for forensic DNA analysis. For the past twenty years, STR loci from the 
human genome have been the genetic markers of choice in forensic DNA analysis in 
large measure. This is because the multi-allelic nature of STRs produce many possible 
genotype combinations that can aid human identification and most importantly DNA 
mixture interpretation. STRs are copied by polymerase chain reaction (PCR) and the 
analysis is performed by size-based DNA separations using capillary electrophoresis 
or CE. However, analysis of PCR product length alone fails to capture the potential 
internal sequence variation that may exist in many STR loci detected via base 
composition mass spectrometry or through full sequence analysis [3].  
1.1.3 Type of STRs 
STR loci can vary in three manners: the repeat unit length (e.g., di-, tri-, tetra-
penta-, hexa-nucleotides), the number of repeat units (e.g.10–25 repeats) and in the 
rigor with which alleles conform to an incremental repeat pattern. In one of the early 
studies by the UK Forensic Science Service (FSS), STR loci were categorized as 







 Simple repeats, such as TH01 with an AATG repeat motif, contain repeat units 
of identical length and sequence, although they may occasionally have non-consensus 
repeats like the TH01 9.3 allele with a [AATG] 6 ATG[AATG] 3 sequence [3].  
Compound repeats comprise two or more adjacent simple repeats, such as 
TCTA and TCTG in the tetranucleotide STR locus vWA. Complex repeats may 
contain several repeat blocks of variable unit length as well as variable interv ening 
sequences with numerous variant alleles, such as the STR loci D21S11 or FGA. Some 
STR alleles contain partial repeats (e.g., the ATG interspersed between AATG repeats 
in the TH01 9.3 allele) or other sequence variation that has arisen due to mutation in 
the repeat region or in the nearby flanking regions [3]. 
Nomenclature for the designation of length-based STR alleles has been 
developed over the years by the DNA Commission of the International Society for 
Forensic Genetics (ISFG) and categorized under simple repeat, variant allele, 
compound repeat and complex repeat [3]. With simple repeats, the number of repeat 
units is counted (e.g., TH01 allele 7). While variant alleles are designated by counting 
the number of full repeats, adding a decimal point, and then counting the number of 
nucleotides (nt) in the incomplete repeat (e.g., TH01 allele 9.3 with nine full repeats 
plus three additional nt). For compound repeats, alleles are designated by counting the 
total number of full repeats (e.g., vWA allele 18 comprised of 1 TCTA + 4 TCTG + 
13 TCTA repeats). With complex repeat systems, the typical approach taken is to 
establish a mathematical relationship to the (nt length of a consensus allele (e.g., 
D21S11 allele 27). For highly variable systems such as SE33, alleles may be identified 
according to their relative size compared to an allelic ladder containing sequenced 






 DNA typing of STRs located in the human genome has proven to be an 
extremely discriminating method for human identification in forensic and paternity 
applications for decades. It has been widely used for the identification of individuals 
based on their DNA characteristics [4]. In forensic applications, STR sequence data is 
expected to increase the effective number of alleles, which may aid mixture 
interpretation in some cases. More generally, this type of data has shown benefits in 
characterizing STR mutation rates which contributes to our foundational 
understanding of these loci [3]. Expansion to additional STRs while retaining 
connection to legacy STR profile information appears to be the way forward in the 
United States and Europe [5]. 
 Single nucleotide polymorphism (SNP) can overcome the technical 
difficulties with the forensic use of STRs. The use of short PCR amplicons (50 nt or 
less) leads to a successful analysis of low amounts of highly degraded DNA, which is 
difficult with highly polymorphic STRs because of their repetitive sequence [6]. 
Furthermore, owing to the very short amplicons that can be employed in SNPs, 
successful SNP profiling can be obtained from degraded DNA which STR profile 
cannot be obtained. SNP profiling lacks artefacts that appears in STR profiles and 
complicates the interpretation of results specially with low amount of DNA [6]. 
However, challenges are also exist with the use of autosomal SNPs for human 
individual identification in forensic investigations. Because SNPs are bi-allelic and 
less polymorphic that multi allelic STRs, they are less informative in the analysis of 
mixtures of DNA from multiple individuals. Therefore, using higher number of SNPs 
may help, but the use of tri-allelic SNPs, combined with multiplex genotyping 






Another forensic approach is using Y-STRs for male identification in mixed 
stain analysis. Since 1990, haplotypes from sets of male specific Y-STRs have been 
used for male identification [6]. The new DNA markers promise to improve human 
identification with the ability to identify two or more male individuals in cases of 
sexual assault. When male contributors are not shown in autosomal STR profiles as a 
result of preferential PCR amplification of the excess female contributor [6].  
Several studies confirmed that Y-STR analysis plays an important role in 
different type of cases such as the analysis of: complex mixtures, sexual cases having 
samples with no spermatozoa [7], samples with multiple contributor mixtures, and 
mixture samples which shows no male component [8]. Commercial kits have been 
improved over years, and more Y- STR multiplexes have been developed [9] which 
provides rich information to be used in constructing phylogenetic trees and the 
deduction of ethnic origin [10].  
1.1.4 Trace DNA Definition 
It is important to understand what is exactly meant by the term trace DNA. 
Nowadays, trace DNA collected from crime scene has become a large part of the 
average forensic laboratories' workload. Remarkably low DNA amounts (<100 pg) 
have been successfully analyzed to obtain profiles from a wide range of sample types. 
Touched objects constitute the most common source of trace DNA, but any type of 
biological material present in low amounts may be considered as trace, including 
minute blood deposits and saliva residue on partially consumed food. In addition to 
supplementing existing analysis techniques in serious crime cases, trace DNA can 
allow investigation of volume crime cases such as burglary, vehicle theft and run over, 






the widespread use of trace DNA, at present there are very few specific validated 
methods. This has led to controversy in the use of trace DNA, and particularly the low 
copy number amplification technique. It has been established that the use of existing 
methodology that specifically developed for high-copy number samples, leads to 
significant levels of artefacts with trace DNA, including allele drop-out and drop-in, 
stutter, and allelic/locus imbalance. To minimize these artefacts, there are numerous 
modifications that can be made to existing methods to increase the success of trace 
DNA analysis. These include reduced extraction volumes, increased cycle number, 
reduced PCR volume, and increased injection time for CE [1]. 
Recent researches have introduced techniques such as post-PCR purification, 
whole genome amplification and molecular crowding which can increase success rates 
with trace DNA significantly. Moreover, each step starts from sample collection, 
extraction, amplification and fragment detection that can be optimized to trace DNA. 
Indeed, the use of trace DNA analysis techniques with high sensitivity must bring an 
increasing awareness of the potential for contamination, both within the laboratory and 
at crime scenes, especially with DNA traces from cold cases, which were not collected 
or stored with highly sensitive DNA detection techniques. Although trace DNA 
continues to be used within forensic biology, a wide range of practices may need to be 
modified to ensure accuracy and reliability [1]. 
1.1.5 DNA Inhibitors 
The most common cause of PCR failure is the presence of PCR inhibitors in 
the samples, especially when dealing with adequate copies of DNA. It causes a great 
challenge for scientist analyzing biological remains recovered from the environment. 






compounds which interfere with downstream DNA typing success, resulting in 
imbalanced, partial or negative DNA profiles. Theoretically, the activity of the 
inhibitors may affect every component of PCR reaction including binding to 
the template DNA, the nt, the amplification primers, Mg2+ and the Taq polymerase 
[11]. 
 Degree of inhibition could have different effect, severe inhibition can lead to 
the loss of alleles from the larger STR loci, or complete false-negative results, which 
is a pattern similar to severe template degradation that can mistakenly attributed. While 
a slight to moderate inhibition which can result in a minor loss of alleles and 
misestimating of the affected sample's DNA quantity, it has potential consequences 
for downstream applications such as STR analysis. Generally, only larger loci are lost 
when the Taq is affected by the inhibitors. However, alleles may be lost regardless of 
amplicon size when inhibitors bind the DNA, based on where in the template the 
inhibitor binds [12, 13]. 
PCR inhibitors associated with casework samples could be humic acid in soil, 
hematin in red blood cells, humic substances in soil, melanin in hair and skin, 
myoglobin in tissue, bile salts and complex polysaccharides in feces, collagen in soft 
tissue and bone, polysaccharides in plants [13, 14]. Moreover, STR typing is limited 
by the quality of human DNA obtained from forensic casework samples that can be 
influenced by environmental factors which may cause different degrees of 
degradation, that have a negative impact on the amplification process especially of 
STR systems with large amplicons [15]. Amplifying of mini STRs, which provides 
shorter length markers, in addition of increasing the amount of classical STRs marker 






1.1.6 DNA Database 
Forensic scientists have become able to identify individuals with a significant 
discrimination power by combining DNA profiling results at several independent STR 
loci. The STR technology is more powerful with the establishment of centralized 
forensic DNA databases in many countries around the world. This is because it 
provides valuable information for direct matching of DNA profiles of individuals to 
those of DNA samples collected at crime scenes. After nearly three decades of 
operation, the size of the centralized DNA database continues to grow [12]. In order 
to reduce the number of adventitious matches and to increase international 
compatibility as well as the power of discrimination for criminal and missing person 
cases, the Federal Bureau of Investigation (FBI) expanded the combined DNA Index 
system (CODIS) core loci from the existing 13 to 20 [5].  
1.1.7 Six-dye STR Kits 
In 2012, a group of scientists started the first beta-testing with a six-dye STR 
kit prototype containing 24 loci (GlobalFilerTM PCR Amplification Kit) developed by 
Life Technologies in response to the CODIS Core Loci Working Group’s 
recommendation to expand the CODIS Core Loci; followed by a validation study of 
these 24 markers in 2014 [16]. Investigator1 24plex QS Kit and Investigator1 24plex 
GO! Kit are other examples of six- dye STR kit containing 24 loci, developed by 
QIAGEN [17]. Another group of scientists proved that with the advancement of the 
six-dye chemistry, it is now possible to expand the number of STR systems analyzed 
within a single reaction, by examining the performance of another six-dye, multiplex 






It is worth mentioning that the six-dye kits allow analyses of a larger volume 
of input DNA (i.e., 15 µL instead of 10 µL). The fact that they possess 8-10 mini-STR 
systems with amplicon sizes of less than 220 bp further improves their information 
recovery from heavily degraded samples [19]. 
In this study, an evaluation of a six-dye STR multiplex assay (VeriFilerTM Plus) 
was conducted; this assay is composed of the following markers: 
- 23 autosomal STR loci (D3S1358, vWA, D16S539, CSF1PO, TPOX, 
D8S1179, D21S11, D18S51, D2S441, D19S433, TH01, FGA, D22S1045, 
D5S818, D13S317, D7S820, D10S1248, D1S1656, D12S391, D2S1338, 
D6S1043, Penta D, Penta E). 
-  1 insertion/deletion polymorphic marker on the Y chromosome (Y indel) 
and Amelogenin (sex-determining marker) 
- 2 internal Quality control markers (IQCL & IQCS) 
Evaluation of the assay with casework samples was performed using a 3500 
genetic analyzer to detect the different fragment size of alleles. This study included the 
analysis of different parameters and aspects; sensitivity study to determine the lowest 
amount of DNA required to produce a complete electropherogram, determination of 
analytical threshold which is the lowest relative fluorescence units (RFU) value at 
which DNA can be distinguished from noise, determination of stochastic threshold 
which is the threshold at which the analyst can be confident that if one peak for a 
heterozygote is above this threshold, then its sister allele will be present and should be 
above the analytical threshold, heterozygous balance which is the relative ratio of two 
alleles at a given locus, determined by dividing the peak height of an allele with a 






and accuracy, reproducibility study is being able to obtain the same result under the 
same condition, genotype concordance is also conducted to assess the success rate of 
the assay, DNA mixtures studies is conducted to define and mimic the range of 
detectable mixture ratios, including detection of major and minor components, and 
stability study to assess the tolerance and the robustness of the assay in the presence 
of common type of inhibitors that could bear in casework samples. 
1.2 Statement of the Problem 
DNA samples collected from a crime scene showed to be the key element in 
solving crimes. However, the traces of DNA samples could be affected by the 
environmental factors which may lead to the loss of the evidence. This study aimed to 
evaluate the use of VerifilerTM Plus, a six-dye multiplex assay, with casework samples. 
This study will be beneficial for DNA forensic laboratories in UAE as well as other 
laboratories, since it enhances the success rate of obtaining positive results from 
challenging forensic samples. 
1.3 Hypothesis and Objectives 
This research study hypothesize that if VerifilerTM Plus is used with casework 
samples, success rate of obtaining positive results will increase. 
The objectives of this study are: 
- To measure the sensitivity, precision, accuracy and reproducibility of the 
VerifilerTM Plus assay, 
- To study mixture sensitivity and inhibition resistance, and 






Chapter 2: Methods 
2.1 Research Design 
2.1.1 Human DNA Samples 
- AmpFLSTR™ Control DNA 007 sourced from Thermo Fisher Scientific 
(South San Francisco, CA), and set of three control DNA SRM 2391c 
purchased from National institute of standard techniques (NIST). 
- A set of 32 consented samples, 16 blood samples and 16 buccal swabs was 
prepared. Samples were extracted using PrepFiler™ Express Forensic DNA 
Extraction Kit (Thermo Fisher Scientific) and the AutoMate Express™ Nucleic 
Acid Extraction System (Thermo Fisher Scientific). The DNA was quantified 
using the Quantifiler™ Human DNA Quantification Kit on an Applied 
Biosystems™ 7500 Real-Time PCR System (Thermo Fisher Scientific). 
- Pre-extracted casework samples, previously analyzed using GlobalFilerTM 
PCR Amplification Kit were used. 
2.1.2 Pre PCR Sample Preparation 
2.1.2.1 Sensitivity Experiments and Determination of Stochastic Thresholds 
A serial dilution of Control DNA 007 (Thermo Fisher Scientific, South San 
Francisco, CA, USA) was amplified using the six-dye multiplex assay (VerifilerTM 
Plus). Four replicate reactions were performed and analyzed with the following inputs: 
1000, 750, 500, 250, 125, 63, 32, 16 and 8 pg DNA. Non-template controls (NTCs) 
were run. Amplified product was electrophoresed on the 3500 instrument and analyzed 






injections were analyzed across the six channels in the range 60–450 base pairs to 
determine the analytical threshold. 
2.1.2.2 Peak Height Ratio 
Data from sensitivity study was used to calculate the heterozygote balance 
(HB) in each dye individually and then all together.  
2.1.2.3 Reproducibility and Allele Call Accuracy  
A total of 34 allelic ladder from two different instruments across multiple 
injections were analyzed, and the average base pair (bp) size and standard deviation 
(SD) of each allele in the allelic ladder was calculated. 
2.1.2.4 DNA Mixture Study 
DNA mixtures was prepared using two male DNA control provided with 
standard SRM 2391c (component B and C) in ratios of 1:1, 3:1, 7:1, 10:1, 15:1 and 
vice versa. Mixtures were amplified in triplicate. Electrophoreses was performed for 
the amplified product on the 3500 instrument and analyzed with GeneMapper™ ID-X 
1.4 software. 
2.1.2.5 Stability Study 
Hematin porcine (Sigma) was prepared at a concentration of 0.6 mM and added 
to the PCR component in the following amount: 1µl, 1.5 µl, 3.125 µl, 6.25 µl, 9.5 µl 
and 12.5 µl. Humic acid (Sigma) was dissolve in water at a concentration of: 200 ng/µl, 






2.1.2.6 Concordance Study 
Standard Reference material SRM-2391c derived from 2 single male donor and 
1 female donor (component A, B and C) produced and certified by the National 
Institute of Standards and Technology (MD, USA) were amplified, and allele calls 
were analyzed against the certified STR allele values. A total of 32 consented samples 
(Ref: DPSC-2019-EA-018), 16 blood samples and 16 buccal swabs were amplified, 
and allele calls were analyzed against profiles from the same set of samples previously 
analyzed using GlobalFilerTM Amplification kit. 
2.1.2.7 Casework Samples 
A total of 8 bone samples (Bn), 7 swabs of bottle (Bt), 5 cigarette butts (CB), 
1 plug, 1 blood from the floor along with a human tissue sample (Ref: DPSC-2019-
EA-018), previously analyzed using GlobalFilerTM Amplification kit, were used to test 
the applicability of the multiplex on casework samples. Controls were amplified along 
with casework samples; amplification reaction was performed with final 
concentrations mentioned in Table 1. PCR was programmed as recommended by 
manufacturer. 
Table 1: Amount of sample needed for PCR reaction 
Sample Add 
Negative control 17.5 μL of nuclease-free water  
Test Sample 17.5 μL of DNA (500 pg) 
Positive control Combined, then added to the reaction tube: 
• 5 μL of DNA Control 007 (0.1 ng/μL) 
• 12.5 μL of nuclease-free water  
Master Mix 5.0 μL 






2.2 PCR Amplification and Thermal Cycling Conditions  
The Master Mix and Primer Set were vortexed for 3 seconds and the tubes were 
centrifuged briefly. Total of 5.0 μL of Master Mix and 2.5 μL of Primer set per sample 
were pipetted into 1.5 ml tube and the reaction mixture was vortexed for 3 seconds, 
then centrifuged briefly and 7.5 μL of reaction mixture was dispensed into each 
MicroAmp™ tube. Samples were prepared and added to the appropriate tube (the final 
reaction volume is 25 μL). The sample input amount volume was adjusted as needed 
to reach DNA input amount of 500 pg. The solution was mixed until it was 
homogenous and each tube was centrifuged at 3,000 rpm for approximately 30 seconds 
in a tabletop centrifuge. 
The thermal cycling conditions was programmed as recommended by 
manufacturer (Table 2). Sample tubes were loaded into the thermal cycler, the heated 
cover was closed, then the run was started. 
Table 2: Thermo cycler program for the assay 
Initial 
incubation 









Hold Cycle (29 Cycle) Hold Hold 
95°C 96°C 62°C 96°C 59°C 60°C 4°C 
1 min 10 sec 90 sec 10 sec 90 sec 5 min ∞ 
 
2.3 Capillary Electrophoresis (CE) 
9.5 µL of Hi-DiTM Formamide, 0.5 µL of GeneScanTM-600 LIZ size standard 
(both from Life Technologies) and 1 µL of amplified sample was added into each well. 






capillary) genetic analyzer (Life Technologies). Data were collected using the 3500 
Data Collection Software v.2.0 and HID files generated with the 3500 Data Collection 






Chapter 3: Results 
3.1 Sensitivity Experiments and Determination of Thresholds 
 Scientist conduct sensitivity tests for number of reasons including the need to 
determine the lowest amount of DNA required to produce a complete 
electropherogram. Different amount of control DNA 007 (Thermo Fisher Scientific) 
was used for sensitivity study.  
To assess this test the percentage of allele call was calculated. Full STR profiles 
(100% of allele call) were obtained from control DNA 007 (Thermo Fisher Scientific) 
samples ranging from 1000 pg down to 63 pg (Figure 1), and drop out was detected 
starting from 32 pg recovering 95% of expected alleles.  
 
Figure 1: Percentage of allele call detected in sensitivity test of template DNA 007 
ranging from 1000-8 pg, n = 27 
Figure 1 illustrates the percentage of allele call resulted from the following 
DNA input of control DNA 007: 1000, 750, 500, 250, 125, 63, 32, 16 and 8 pg. 70% 
































Figure 2: Average peak height of control DNA 007 ranging from 1000-8 pg in 
sensitivity test, n = 27 
Overall, as the DNA input decrease, the average peak height of the alleles also 
decrease (Figure 2); indicating decrease of the quality and the completeness of the 
profiles. This result shows well correlation between the signal height and the serially 




























Table 3: Illustration of allele dropout in template DNA input ranging from 1000-8 pg 
Marker 
DNA Template Amount 
1000 pg 750 pg 500 pg 250 pg 125 pg 63 pg 32 pg 16pg 8pg 
D3S1358                   
vWA                   
D16S539                   
CSF1PO                   
D6S1043                   
Yindel                   
AMEL                   
D8S1179                   
D21S11                   
D18S51                   
D5S818                   
D2S441                   
D19S433                   
FGA                   
D10S1248                   
D22S1045                   
D1S1656                   
D13S317                   
D7S820                   
Penta E                   
Penta D          
TH01          
D12S391          
D2S1338          
TPOX          
Note: Green wells represent full allele call, yellow wells represent allele drop out. 
The number of dropouts increase with decreasing the input amount of DNA 
(Table 3). Profiles generated from 32 pg of DNA input showed two allele dropouts, 
detected in D3S1358 (Blue Dye) and D8S1179 (Green Dye). For 16 pg of DNA input, 
allele dropout was detected in the Blue Dye (CSF1PO, D6S1043), Green Dye 
(D18S51, D5S818), Yellow Dye (D2S441, D10S1248) and in the Purple Dye 
(D12S391). Total of 11 allele dropout was detected in the 5 dyes of profiles generated 
from 8 pg DNA template (Table 3). No locus dropout was detected. A number of pull 






distinguishable from the true allele peaks, which points to the optimum range to be 
determined at 125 - 500 pg. All the alleles in those profiles remained balanced and was 
not affected with the pull up peaks.  
Analytical threshold (AT) is the minimum height requirement, above which 
detected peaks can be reliably distinguished from background noise; peaks above this 
threshold are generally not considered noise and are either artifacts or true alleles. It 
was calculated using the following formula: AT= 2 x (Max. PH – Min. PH) [22]. To 
calculate AT two different set of samples were used to calculate an acurate AT for 
casework samples.  
The first set is composed of 11 negative controls from multiple injections, 
where the analysis of baseline noise was conducted, and the AT calculated from these 
set was (36.8 RFU) (Table 4) which is conciderd to be very low AT and might cause 
an increase in the baseline noise if a mass of DNA amount (>1 ng) was amplified. Alot 
of pull ups to be called specially with strong DNA input samples. However this low 
threshold can be usefull with casework sampls of low DNA amount.  
Table 4: Analytical threshold (AT) calculated from negative control samples 
Dye Max. PH Min. PH AT= 2 * (Max. PH – Min. PH), Average AT 
blue 19 2 34 
36.8 
Green 20 4 32 
yellow 26 1 50 
red 17 2 30 
Purple 22 3 38 






The second set composed of positive control samples from sensitivity study. 
Calls for all true alleles and artefactes were removed, and the minimum and maximum 
peak heigt of the identified baseline noise was calculated in each dye channel. The 
average AT for all dyes is 76.8 RFU (Table 5), so the overall analytical threshold was 
set to 80 RFU.  
Table 5: Analytical threshold (AT) calculated from sensitivity study 
Dye Max. PH Min. PH AT= 2 * (Max. PH – Min. PH) Average AT 
Blue 30 1 58 
76.8 
Green 33 3 60 
Yellow 37 2 70 
Red 60 3 114 
Purple 45 4 82 
Max. PH: Maximum peak height; Min. PH: Minimum peak height 
The stochastic threshold (ST) is the threshold at which the analyst can be 
confident that if one peak for a heterozygote is above this threshold, then its sister 
allele will be present and should be above the analytical threshold; it is the peak height 
value above which it is reasonable to assume that, at a given locus, allelic dropout of 
a sister allele has not occurred. This can be described as the limit of quantification 
(LOQ). The stochastic threshold was calculated using the following formula: Average 
peak height + (3 x SD). It was calculated by examining the peak height of heterozygote 
loci where one sister allele has dropped below the analytical threshold. The highest 
peak height recorded was 179 RFU and the overall stochastic threshold was set to 180 







Table 6: Stochastic threshold (ST) calculation 
Average in all dye channel SD ST= Average Peak Height + (3* SD) ST 
113.5 22.14 179.9 180 
SD: Standard deviation. 
3.2 Heterozygote Balance (HB) 
The HB is the relative ratio of two alleles at a given locus, as determined by 
dividing the peak height of an allele with a lower RFU value by the peak height of an 
allele with a higher RFU value, and then multiplying this value by 100 to express the 
PHR as a percentage. HB is used as an indication of which alleles may be heterozygous 








Figure 3: Peak height ratio for each dye channel observed in sensitivity study (a) blue 
dye channel, (b) green dye channel, (c) yellow dye channel, (d) red dye channel, (e) 
purple dye channel 
HB was calculated individually for each dye (Figure 3). According to the 
recommendations of ENFSI [23, 24] the peak balance ratio of heterozygote alleles 
should be > 60%. PHR was below 60% when the peak height of the allelic pair was 
lower than 250 RFU in the blue, green, red and purple dye (Figure 3 a, b, d, e) showing 
that heterozygous peak height ratios decreased towards lower template amounts. All 







Figure 4: Heterozygote balance average in all dye channels 
The overall peak height ratio in all markers is illustrated in Figure 4. The 
average peak height ratio varied between 99- 60% which meets the recommendation 
of ENFSI. Overall, HB increase toward higher allele peak heights. 
Peak height ratio comparison was done between DNA profiles with 500 pg 
DNA input, which is considered to be the intermediate amount of DNA input, and 
DNA profile with 16 pg DNA input (low amount of DNA) using t-test. A p- value = 
5.56343E-09 was obtained which is significantly less than α (0.05), and t-stat = 
6.761035004 (Table 7). This result provides strong evidence that the amount of input 
DNA affects the peak height ratio balance producing lower ratios toward lower DNA 
input. This result might help the scientist to make correct decision about profiles 



























Table 7: T-test comparing HB between 16 pg and 500 pg DNA input 
  16 pg DNA 500 pg DNA 
Mean 0.603072681 0.840966 
Variance 0.03296552 0.006652 
Observations 32 32 
Pooled Variance 0.019808752 
 




t Stat -6.761035004 
 
P(T<=t) one-tail 2.78172E-09 
 
t Critical one-tail 1.669804163 
 
P(T<=t) two-tail 5.56343E-09 
 
t Critical two-tail 1.998971517   
 
3.3 Reproducibility  
Reproducibility is the test of being able to obtain the same result under the 
same condition. To test for reproducibility of genotyping results across different sites 
and instruments, 500 pg as input DNA (Table 8) of Control DNA 007 was amplified 







Table 8: Allele call of control DNA 007 replicates 
Marker Allele call of each sample 













D3S1358 15,16 15,16 15,16 15,16 15,16 15,16 
vWA 14,16 14,16 14,16 14,16 14,16 14,16 
D16S539 9,10 9,10 9,10 9,10 9,10 9,10 
CSF1PO 11,12 11,12 11,12 11,12 11,12 11,12 
D6S1043 12,14 12,14 12,14 12,14 12,14 12,14 
Yindel 2 2 2 2 2 2 
AMEL XY XY XY XY XY XY 
D8S1179 12,13 12,13 12,13 12,13 12,13 12,13 
D21S11 28,31 28,31 28,31 28,31 28,31 28,31 
D18S51 12,15 12,15 12,15 12,15 12,15 12,15 
D5S818 11 11 11 11 11 11 
D2S441 14,15 14,15 14,15 14,15 14,15 14,15 
D19S433 14,15 14,15 14,15 14,15 14,15 14,15  
FGA 24,26 24,26 24,26 24,26 24,26 24,26 
D10S1248 12,15 12,15 12,15 12,15 12,15 12,15 
D22S1045 11,16 11,16 11,16 11,16 11,16 11,16 
D1S1656 13,16 13,16 13,16 13,16 13,16 13,16 
D13S317 11,11 11,11 11,11 11,11 11,11 11,11 
D7S820 7,12 7,12 7,12 7,12 7,12 7,12 
Penta E 7,12 7,12 7,12 7,12 7,12 7,12 
Penta D 11,12 11,12 11,12 11,12 11,12 11,12 
TH01 7,9.3 7,9.3 7,9.3 7,9.3 7,9.3 7,9.3 
D12S391 18,19 18,19 18,19 18,19 18,19 18,19 
D2S1338 20,23 20,23 20,23 20,23 20,23 20,23 
TPOX 8,8 8,8 8,8 8,8 8,8 8,8 
 
3.4 Allele Call Accuracy and Size Precision 
To measure the degree of variation in each fragment size, a total of 34 replicates 








Figure 5: Average SD of allele size in each marker, n= 34 
The average SD of all allele size (bp) in every loci between all replicates varied 
from 0.02 to 0.08 bp (Figure 5), which is within the recommended ± 0.5 bp window 
for genotyping as it is mentioned by ENFSI (2010) [23]. 
 












































































































































































































No dropout was observed in any allelic ladder. Size variation increases with 
larger fragment size (Figure 6). Average length and SDs were determined for each 
allelic ladder fragment across all dye channels (Figures 7-11). 
 
Figure 7: Allele range and detection size precision for each marker in the blue dye 
Figure 7a illustrates the minimum SD which was observed for D3S1358 allele 
15. While average SD of each fragment size varies between 0.02 bp to 0.08 bp among 







Figure 8: Allele range and detection size precision for each marker in the green dye 
Figure 8 illustrates the average SD of each fragment size in 6 markers of green 







Figure 9: Allele range and detection size precision for each marker in the yellow dye 
Figure 9 illustrates the average SD of each fragment size in 4 markers of yellow 







Figure 10: Allele range and detection size precision for each marker in the red dye 
Figure 10 illustrates the average SD of each fragment size varies between 0.02 







Figure 11: Allele range and detection size precision for each marker in the purple dye 
Figure 11c illustrates the maximum SD which was observed for TPOX allele 
10 in the purple dye channel. While the average SD of each fragment size in this dye 
channel varies between 0.02 bp and 0.09 bp (Figure 11). 
ANOVA test was performed to compare the average size of each fragments in 
allelic ladder used in the precision study. Results are summarized in Table 9. F- value 
is less than F-critical, confirming that there is no significant difference between the 






than the confidence interval α= 0.05, which also shows that there is no significant 
difference between the mean value.  
Table 9: ANOVA test comparing 11 allelic ladders (AL) from one instrument 
SUMMARY 
     
Groups Count Sum Average Variance 
  
AL1 362 89148.79 246.2674 9122.487 
  
AL2 362 89166.62 246.3166 9125.084 
  
AL3 362 89168.78 246.3226 9120.824 
  
AL4 362 89161.4 246.3022 9120.676 
  
AL5 362 89152.5 246.2776 9119.444 
  
AL6 362 89152.62 246.278 9117.448 
  
AL7 362 89156.5 246.2887 9120.728 
  
AL8 362 89157.27 246.2908 9121.239 
  
AL9 362 89155.43 246.2857 9118.195 
  
AL10 362 89157.66 246.2919 9119.563 
  
AL11 362 89165.3 246.313 9124.789 
  
       
ANOVA 
      
Source of Variation SS df MS F P-value F crit 
Between Groups 1.12356 10 0.112356 1.23E-05 1 1.833081 
Within Groups 36219302 3971 9120.952 
   
       
Total 36219303 3981         
 
Average SD of the fragment size was calculated for the 34 allelic ladders from 
multiple injection in two different instruments and the results (Table 10) support the 
finding in Table 9. F- value (0.000231) is less than F-critical (1.43732) and P value = 








Table 10: ANOVA test comparing 34 allelic ladders (AL) from 2 instruments 
SUMMARY 
     
Groups Count Sum Average Variance 
  
AL 1 362 89148.79 246.2674 9122.487 
  
AL 2 362 89166.62 246.3166 9125.084 
  
AL 3 362 89168.78 246.3226 9120.824 
  
AL 4 362 89161.4 246.3022 9120.676 
  
AL 5 362 89152.5 246.2776 9119.444 
  
AL 6 362 89152.62 246.278 9117.448 
  
AL 7 362 89156.5 246.2887 9120.728 
  
AL 8 362 89157.27 246.2908 9121.239 
  
AL 9 362 89155.43 246.2857 9118.195 
  
AL 10 362 89157.66 246.2919 9119.563 
  
AL 11 362 89165.3 246.313 9124.789 
  
AL 12 362 89130.22 246.2161 9124.238 
  
AL 13 362 89135.45 246.2305 9122.788 
  
AL 14 362 89084.85 246.0907 9127.425 
  
AL 15 362 89135.44 246.2305 9126.821 
  
AL 16 362 89140.93 246.2457 9126.125 
  
AL 17 362 89084.97 246.0911 9130.639 
  
AL 18 362 89165.8 246.3144 9124.826 
  
AL 19 362 89134.89 246.229 9119.312 
  
AL 20 362 89149.51 246.2694 9121.287 
  
AL 21 362 89154.69 246.2837 9124.201 
  
AL 22 362 89136.38 246.2331 9120.749 
  
AL 23 362 89146.91 246.2622 9125.475 
  
AL 24 362 89138.05 246.2377 9120.773 
  
AL 25 362 89154.29 246.2826 9117.779 
  
AL 26 362 89180.4 246.3547 9115.658 
  
AL 27 362 89102.77 246.1402 9130.976 
  
AL 28 362 89140.33 246.244 9118.91 
  
AL 29 362 89174.27 246.3378 9118.941 
  
AL 30 362 89185.58 246.369 9117.593 
  
AL 31 362 89101.27 246.1361 9128.724 
  
AL 32 362 89190.23 246.3819 9120.295 
  
AL 33 362 89103.56 246.1424 9131.32 
  
AL 34 362 89090.07 246.1052 9130.612 
  
       
ANOVA 
      
Source of Variation SS df MS F P-value F crit 
Between Groups 69.41863 33 2.103595 0.000231 1 1.43732 
Within Groups 1.12E+08 12274 9122.822 
   
       







3.5 DNA Mixture Study 
Mixture study is conducted to define and mimic the range of detectable mixture 
ratios, including detection of major and minor components. To assess the ability to 
resolve minor contributor alleles with the assay, a study was performed with nine 
mixture sample of male: male at different ratios (1:1, 3:1, 7:1, 10:1, 15:1 and vice 
versa) (Appendix 1) using standard SRM 2391c (component B and C). The total 
amount of mixed DNA used in this study was 500 pg (Table 11); a 15:1 mixture thus 
contains 30 pg of the minor component DNA and 470 pg of the major component. 
Samples were run in replicates of 4. The limit of detection of the minor component 
was determined by analyzing non-overlapping alleles of both DNAs. 
Table 11 illustrates the % of detected alleles in each mixture. Full STR profile 
was obtained until the 1:3 ratio (130 pg for the minor contributor). 98% of expected 
alleles were identified for minor components of 1:7, 7:1 and 10:1 mixture, and 96% 
for 1:10 mixture. For 15:1 91% of the minor component alleles were identified. 
Table 11: Mixture study 
Mixture ratio Total DNA input 
(pg) 
Number of detected alleles 
in the mixture 
% of detected 
alleles in the 
mixture 
1:15 30 / 470 55/59 93 
1:10 43 /457 57/59 96.6 
1:7 63 / 437 58/59 98 
1:3 130 / 370 59/59 100 
1:1 250 / 250 59/59 100 
3:1 370 / 130 59/59 100 
7:1 437/ 63 58/59 98 
10:1 457 / 43 58/59 98 







3.6 Stability Study 
Two set of different PCR inhibitors was used to assess the tolerance of 
VerifilerTM Plus and 500 pg of control DNA 007 was used as a template. PCR was 
performed under standard conditions. Performance levels were assessed based on the 
number of alleles correctly called. 
 
Figure 12: The effect of hematin porcine 0.6 mM on allele detection of DNA control 
007 
In the first set, hematin porcine (0.6mM) was added to the PCR reactions in 
the following amounts: 1, 1.5, 3.125, 6.25, 9.5 and 12.5 µl. Full profile were generated 
in the presence of 6.25 µl, with no alleles being detected in the presence of 9.5 µl and 


































Figure 13: The effect of humic acid on allele detection of DNA control 007 
In another set of experiment, humic acid was added in different concentrations 
ranging from 60 - 200 ng/µl. Full profiles were generated for all concentrations tested 
(up to 200 ng/µl) (Figure 13). 
3.7 Success Rate and Concordance 
Concordance study was conducted to assess the success rate of the assay. A 
total of 16 blood samples on FTA card, which were directly amplified, and another 16 
buccal swabs along with 3 samples from the Standard Reference Materials 2391c 
(component A, B and C) were analyzed using this multiplex. The success rate was 
100%. All genotyping was performed with GeneMapper ID-X v1.4 software. Data 
tables were exported into Microsoft Excel and compared to data generated previously 
with the Applied Biosystem GlobalFilerTM PCR kit. Allele call of Components A, B 
and C were analyzed against the certified STR allele values. All 35 samples were 100% 

































3.8 Casework Samples 
A study was performed to assess the ability to obtain reliable results from 
casework samples that represent the typical variation in DNA quantity and quality 
encountered with samples received by forensic laboratories. Different casework 
samples with different ranges of concentration which can impact the result and the 
interpretation of obtained data were selectively chose and tested to assess the 
performance of the assay. Eight Bn, 7 Bt, 5 CB, 1 P, 1 Bl along with Ts were analyzed 
and compared with data previously obtained using GlobalFilerTM PCR kit (Table 12). 
Almost all of the samples tested yielded more alleles compared to the results 
previously obtained with GlobalFilerTM PCR kit (Figure 16). While the DNA 
concentration in swab of bottle-4 (Bt 4) (4 ng/µl) is lower than DNA concentration in 
cigarette butt-1 (CB 1) (8 pg/ µl), The number of allele call in (Bt 4) is significantly 
higher than the number obtained in (CB 1). This could be due to the presence of 
potential PCR inhibitors in the cigarette butt such as: tars and phenolics from the 







Table 12: Different casework samples used to assess the multiplex assay 
Sample Sample DNA Allele called % of total alleles  
pg/µl GF VFP GF VFP 
CB 1 8 8 18 17 36 
CB 2 400 46 49 100 100 
CB 3 1200 46 49 100 100 
CB 4 200 46 49 100 100 
CB 5 1000 46 49 100 100 
Bt 1 30 43 49 93 100 
Bt 2 100 46 49 100 100 
Bt 3 30 46 49 100 100 
Bt 4 4 30 49 65 100 
Bt 5 90 46 49 100 100 
Bt 6 80 46 49 100 100 
Bt 7 400 46 49 100 100 
Ts 400 39 49 84 100 
P 600 35 48 76 98 
Bl 1400 46 49 100 100 
Bn 1 60 46 49 100 100 
Bn 2 20 46 49 100 100 
Bn 3 30 46 49 100 100 
Bn 4 30 46 49 100 100 
Bn 5 30 44 49 100 100 
Bn 6 16 43 46 93 94 
Bn 7 20 46 49 100 100 
Bn 8 500 46 49 100 100 
CB: cigarette butt; Bt: bottle; Ts: human tissue; P: plug; Bl: blood; Bn: bone 
 



















Figure 14: Electropherogram of DNA control 007 with 500 pg (Continued) 
Figure 14 illustrates a full profile obtained from 500 pg of DNA control 007 















Figure 15: Electropherogram of a cigarette butt sample (1000 pg) (Continued) 
Generally, profiles obtained from VerifilerTM Plus recorded higher peak 








Figure 16: Electropherogram of a swab of bottle (30 pg) using two PCR assays 
Figure 16 illustrates a comparison between the number of alleles generated 
from the same swab of bottle using VerifilerTM Plus and GlobalFilerTM PCR kit. 









Figure 17: Illustration of two internal quality control sensors 
 
Figure 18: Interpretation of the sample in the presence of IQC 
Two internal quality control sensors are included in this assay which provides 
extra information on the quality and the integrity of DNA sample (Figure 17). It can 
evaluate the PCR reaction, infer possible sample degradation or inhibition. 
 In Figure 18, both IQC sensors are > 2000 rfu which indicates successful PCR 
reaction was performed [27], while a ski slope pattern observed in the DNA profile 































Figure 20: Electropherogram of blood sample (1400 pg) (Continued) 
The main results in this study highlight the minimum DNA input required to 
generate a full profile is 63 pg (Figure 19). The AT was set to 80 RFU while the SD 
was set to 150 RFU. Size precision of VerifilerTM Plus PCR kit varied between 0.02 
bp and 0.08 bp. Samples were 100% concordance and the success rate of generated 
profiles was 100%. The assay showed high tolerance toward humic acid (60-200 ng/µl) 






Chapter 4: Discussion 
This study is the first to evaluate the performance of (VeriFilerTM Plus) a six-
dye STR multiplex assay with casework samples in forensic applications. Sensitivity 
of the assay toward DNA template input was tested and full STR profiles (100% of 
allele call) were obtained from all the samples ranging from 1000 pg down to 63 pg 
showing consistent result with a study conducted using  AmpFlSTR® NGM SElect™ 
PCR Amplification Kit [20].  
However, it shows higher sensitivity compared to two other six-dye 
multiplexes, GlobalFiler® PCR Amplification and Investigator® 24plex QS kits [4,17, 
21]. 95% of expected alleles were recoverd from 32 pg DNA, which is significantly 
higher than the percentage of recovered allele at 32 pg in GlobalFiler® PCR 
Amplification [16]. 70% and 52% of all expected alleles were recovered at 16 pg and 
8 pg respectively. A study reported that the Investigator® kit produced 50% of expected 
alleles with 8 pg of DNA [17] which is more consistent with result obtained from 8 pg 
DNA.  
Sizing Precision is critical for determination of correct genotyping. Therefore, 
migration of each fragment and sizing precision must be consistent and within the bin 
window to ensure proper allele designation. The degree of variation generated in this 
study was between 0.02 bp and 0.08 bp which is within the recommended bin window 
for genotyping as it is mentioned by ENFSI (2010) [23] showing similar results to 
other studies conducted in this field [17, 25].  
Mixture study can be used to assist forensic laboratories in establishing 






to the results obtained from GlobalFiler Amplification kit, there is no significant 
difference [4].  
Due to the wide range of forensic sample types and the different sampling 
models in the crime scene, substances known to be inhibitory toward PCR reactions 
are often encountered in DNA extracted from casework samples resulting either in loss 
of peaks or lowering of peak heights. Inhibition study was conducted to assess the 
tolerance and the robustness of the assay in the presence of common type of inhibitors 
that could bear in casework samples. Hematin porcine (0.6 mM), formed by the 
oxidation of heme which is the main component of blood and humic acid (60-200 
ng/µl), a principle component of humic substances that may present in forensic 
samples collected from soil [17]. Full profiles were generated for all humic acid 
concentrations tested (up to 200 ng/µl). This is in agreement with findings in other 
studies [17]. These data demonstrate that this essay can generate a high number of 






Chapter 5: Conclusion 
This study was conducted to assess and evaluate the performance of the 6-dye 
multiplex assay containing 23 autosomal loci with casework samples. The result of 
each quality control test was analyzed, sensitivity test results showed the minimum 
amount of DNA input resulting in a full DNA profile was 63 pg. However, the 
optimum range determined was 125 - 500 pg. Minimal limit of detection was 
calculated for every dye set, and the result obtained was used to estimate the overall 
analytical threshold at 80 RFU. Stochastic threshold calculation resulted in highest 
value to be set at 180 RFU. Heterozygous alleles were balanced for total DNA input 
ranging from 1000 - 500 pg while it was less than 60% for samples with total DNA 
input below 250 pg. All expected alleles were detected for minor contributor of 1:1, 
1:3, mixture ratios, however 98% of alleles were detected for the minor contributor of 
1:7, 10:1 mixture ratio. For 15:1 91% of the alleles were detected. Stability study 
demonstrated that this assay can generate a high number of alleles in the presence of 
of Hematin porcine (0.6 mM) and humic acid (200 ng/µl). DNA profile results are 
concordant to those obtained from Applied Biosystem GlobalFilerTM PCR kit.  
Overall, this study demonstrate that the assay can produce reliable and 
reproducible results, and it enhances the success rate of obtaining positive results from 
challenging forensic samples. This assay is fit to be used with casework samples in 
forensic DNA identification. Further studies are recommended to assess the resistance 
of this assay toward other PCR inhibitors such as inhibitors encountered in cigarette 
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- Sample setup for Mixture study using Component B and C (1.6 ng/µl) 
o Samples were diluted to reach a final concentration of 0.5 ng/ µl in 
100 µl. To prepare a stock solution for each component (B & C), 
31.25 µl was added to 68.75 µl of the diluent.  
o Mixtures were prepared using the following amounts:  
 
Table 13: Volume of each diluted DNA sample required to prepare mixture set 1 
Ratio Volume of B (µl) Volume of C (µl) 
1:1 8.75 8.75 
3:1 13.1 4.4 
7:1 15.3 2.2 
10:1 16 1.5 
15:1 16.5 1 
 
Table 14: Volume of each diluted DNA sample required to prepare mixture set 2 
Ratio Volume of C (µl) Volume of B (µl) 
1:3 13.1 4.4 
1:7 15.3 2.2 
1:10 16 1.5 










Table 15: Concordance study with SRM 2391c samples (component A, B and C) 
sample markers Verifiler Plus Certificate of Ananlysis- Standard 
Reference Material 2391c 
A D3S1358 15 16 15 16  
vWA 18 19 18 19  
D16S539 10 11 10 11  
CSF1PO 10 10 10 10  
D6S1043 11 18 11 18  
Yindel          
AMEL X X X X  
D8S1179 13 14 13 14  
D21S11 28 32.2 28 32.2  
D18S51 12 15 12 15  
D5S818 11 12 11 12  
D2S441 10 10 10 10  
D19S433 13 14 13 14  
FGA 21 23 21 23  
D10S1248 15 16 15 16  
D22S1045 15 15 15 15  
D1S1656 17.3 17.3 17.3 17.3  
D13S317 8 8 8 8  
D7S820 11 11 11 11  
Penta E 5 10 5 10  
Penta D 9 13 9 13  
TH01 8 9.3 8 9.3  
D12S391 18.3 22 18.3 22  
D2S1338 18 23 18 23  
TPOX 8 8 8 8 
B D3S1358 15 19 15 19  
vWA 17 18 17 18  
D16S539 10 13 10 13  
CSF1PO 10 11 10 11  
D6S1043 14 19 14 19  
Yindel 2        
AMEL X Y X Y  
D8S1179 10 13 10 13  
D21S11 32 32.2 32 32.2  
D18S51 13 16 13 16  
D5S818 12 13 12 13  
D2S441 10 14 10 14  
D19S433 16 16.2 16 16.2  






Table 15: Concordance study with SRM 2391c sample (component A, B and C) 
(continued) 
sample markers Verifiler Plus Certificate of Ananlysis- Standard 
Reference Material 2391c 
B D10S1248 13 13 13 13  
D22S1045 15 17 15 17  
D1S1656 11 14 11 14  
D13S317 9 12 9 12  
D7S820 10 10 10 10  
Penta E 7 15 7 15  
Penta D 8 12 8 12  
TH01 6 9.3 6 9.3  
D12S391 19 24 19 24  
D2S1338 17 17 17 17  
TPOX 8 11 8 11 
C D3S1358 16 18 16 18  
vWA 16 18 16 18  
D16S539 10 10 10 10  
CSF1PO 10 12 10 12  
D6S1043 11 14 11 14  
Yindel 2        
AMEL X Y X Y  
D8S1179 10 17 10 17  
D21S11 29 30 29 30  
D18S51 16 19 16 19  
D5S818 10 11 10 11  
D2S441 10 10 10 10  
D19S433 13.2 15.2 13.2 15.2  
FGA 24 26 24 26  
D10S1248 12 16 12 16  
D22S1045 16 16 16 16  
D1S1656 11 15 11 15  
D13S317 11 11 11 11  
D7S820 10 12 10 12  
Penta E 12 13 12 13  
Penta D 10 11 10 11  
TH01 6 8 6 8  
D12S391 19 23 19 23  
D2S1338 19 19 19 19  








Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits 
Sample markers GF markers VFP- Blood VFP- Buccal swab 
1 D3S1358 15 18 D3S1358 15 18 15 18 
vWA 15 17 vWA 15 17 15 17 
D16S539 10 12 D16S539 10 12 10 12 
CSF1PO 11 12 CSF1PO 11 12 11 12 
TPOX 8 8 D6S1043 12 17 12 17 
Yindel 2   Yindel 2   2   
AMEL X Y AMEL X Y X Y 
D8S1179 14 14 D8S1179 14 14 14 14 
D21S11 28 29 D21S11 28 29 28 29 
D18S51 14 14 D18S51 14 14 14 14 
DYS391 10 10 D5S818 11 12 11 12 
D2S441 10 14 D2S441 10 14 10 14 
D19S433 14 15 D19S433 14 15 14 15 
 TH01 7 8 FGA 21 24 21 24  
FGA 21 24 D10S1248 15 16 15 16 
D22S1045 11 15 D22S1045 11 15 11 15 
D5S818 11 12 D1S1656 17 17.3 17 17.3 
D13S317 11 13 D13S317 11 13 11 13 
D7S820 10 11 D7S820 10 11 10 11 
SE33 19 27.2 Penta E 7 10 7 10 
D10S1248 15 16 Penta D 11 12 11 12 
D1S1656 17 17.3 TH01 7 8 7 8 
D12S391 22 24 D12S391 22 24 22 24 
D2S1338 18 23 D2S1338 18 23 18 23 
      TPOX 8 8 8 8 
2 D3S1358 15 15 D3S1358 15 15 15 15 
vWA 17 18 vWA 17 18 17 18 
D16S539 9 13 D16S539 9 13 9 13 
CSF1PO 12 12 CSF1PO 12 12 12 12 
TPOX 8 11 D6S1043 11 14 11 14 
Yindel     Yindel         
AMEL X X AMEL X X X X 
D8S1179 12 13 D8S1179 12 13 12 13 
D21S11 28 30 D21S11 28 30 28 30 
D18S51 12 14 D18S51 12 14 12 14 
DYS391     D5S818 12 13 12 13 
D2S441 11 11 D2S441 11 11 11 11 
D19S433 13 14 D19S433 13 14 13 14 
TH01 6 7 FGA 19 25 19 25 
FGA 19 25 D10S1248 13 14 13 14 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued) 
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
D5S818 12 13 D1S1656 12 16 12 16 
D13S317 12 12 D13S317 12 12 12 12 
D7S820 8 11 D7S820 8 11 8 11 
SE33 28.2 29.2 Penta E 5 19 5 19 
D10S1248 13 14 Penta D 12 14 12 14 
D1S1656 12 16 TH01 6 7 6 7 
D12S391 18 18 D12S391 18 18 18 18 
D2S1338 17 19 D2S1338 17 19 17 19 
      TPOX 8 11 8 11 
3 D3S1358 15 18 D3S1358 15 18 15 18 
vWA 17 18 vWA 17 18 17 18 
D16S539 12 13 D16S539 12 13 12 13 
CSF1PO 11 12 CSF1PO 11 12 11 12 
 TPOX 8 8 D6S1043 11 13 11 13 
 Yindel     Yindel         
 AMEL X X AMEL X X X X  
D8S1179 15 16 D8S1179 15 16 15 16 
D21S11 29 31 D21S11 29 31 29 31 
D18S51 16 17 D18S51 16 17 16 17 
DYS391     D5S818 12 13 12 13 
D2S441 11 14 D2S441 11 14 11 14 
D19S433 15 15.2 D19S433 15 15.2 15 15.2 
TH01 6 6 FGA 22 22 22 22 
FGA 22 22 D10S1248 14 15 14 15 
D22S1045 15 16 D22S1045 15 16 15 16 
D5S818 12 13 D1S1656 11 17 11 17 
D13S317 8 13 D13S317 8 13 8 13 
D7S820 10 11 D7S820 10 11 10 11 
SE33 23.2 36 Penta E 12 13 12 13 
D10S1248 14 15 Penta D 11 14 11 14 
D1S1656 11 17 TH01 6 6 6 6 
D12S391 17 18 D12S391 17 18 17 18 
D2S1338 19 19 D2S1338 19 19 19 19 
      TPOX 8 8 8 8 
4 D3S1358 15 18 D3S1358 15 18 15 18 
vWA 17 18 vWA 17 18 17 18 
D16S539 12 12 D16S539 12 12 12 12 
CSF1PO 12 12 CSF1PO 12 12 12 12 
TPOX 8 11 D6S1043 11 19 11 19 
Yindel     Yindel         






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
D8S1179 12 13 D8S1179 12 13 12 13 
D21S11 29 29 D21S11 29 29 29 29 
D18S51 14 15 D18S51 14 15 14 15 
DYS391     D5S818 13 13 13 13 
D2S441 11 14 D2S441 11 14 11 14 
D19S433 13 14 D19S433 13 14 13 14 
TH01 6 9 FGA 21 23 21 23 
FGA 21 23 D10S1248 14 15 14 15 
D22S1045 15 15 D22S1045 15 15 15 15 
D5S818 13 13 D1S1656 15 17.3 15 17.3 
D13S317 11 12 D13S317 11 12 11 12 
D7S820 9 11 D7S820 9 11 9 11 
SE33 18 21.1 Penta E 5 13 5 13 
 D10S1248 14 15 Penta D 9 9 9 9 
 D1S1656 15 17.3 TH01 6 9 6 9 
 D12S391 20 23 D12S391 20 23 20 23 
 D2S1338 17 21 D2S1338 17 21 17 21 
       TPOX 8 11 8 11 
5 D3S1358 16 17 D3S1358 16 17 16 17 
vWA 17 17 vWA 17 17 17 17 
D16S539 10 14 D16S539 10 14 10 14 
CSF1PO 11 12 CSF1PO 11 12 11 12 
TPOX 8 8 D6S1043 11 11 11 11 
Yindel     Yindel         
AMEL X X AMEL X X X X 
D8S1179 11 13 D8S1179 11 13 11 13 
D21S11 29 32.2 D21S11 29 32.2 29 32.2 
D18S51 16 18 D18S51 16 18 16 18 
DYS391     D5S818 10 11 10 11 
D2S441 10 12 D2S441 10 12 10 12 
D19S433 13 14 D19S433 13 14 13 14 
TH01 6 9 FGA 20 23 20 23 
FGA 20 23 D10S1248 15 15 15 15 
D22S1045 11 15 D22S1045 11 15 11 15 
D5S818 10 11 D1S1656 11 17.3 11 17.3 
D13S317 14 14 D13S317 14 14 14 14 
D7S820 9 10 D7S820 9 10 9 10 
SE33 18 20.2 Penta E 7 OL 7 OL 
D10S1248 15 15 Penta D 11 12 11 12 
D1S1656 11 17.3 TH01 6 9 6 9 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
D2S1338 19 19 D2S1338 19 19 19 19 
      TPOX 8 8 8 8 
6 D3S1358 17 18 D3S1358 17 18 17 18 
vWA 14 14 vWA 14 14 14 14 
D16S539 9 9 D16S539 9 9 9 9 
CSF1PO 10 12 CSF1PO 10 12 10 12 
TPOX 8 8 D6S1043 12 18 12 18 
Yindel     Yindel         
AMEL X X AMEL X X X X 
D8S1179 13 13 D8S1179 13 13 13 13 
D21S11 31 32 D21S11 31 32 31 32 
D18S51 12 16 D18S51 12 16 12 16 
DYS391     D5S818 10 12 10 12 
 D2S441 10 12 D2S441 10 12 10 12 
 D19S433 13.2 14 D19S433 13.2 14 13.2 14 
 TH01 9 9 FGA 21 24 21 24 
 FGA 21 24 D10S1248 13 14 13 14 
 D22S1045 15 15 D22S1045 15 15 15 15 
 D5S818 10 12 D1S1656 16 16 16 16 
 D13S317 9 12 D13S317 9 12 9 12  
D7S820 11 13 D7S820 11 13 11 13 
SE33 25.2 27.2 Penta E 11 17 11 17 
D10S1248 13 14 Penta D 10 11 10 11 
D1S1656 16 16 TH01 9 9 9 9 
D12S391 18 25 D12S391 18 25 18 25 
D2S1338 19 21 D2S1338 19 21 19 21 
      TPOX 8 8 8 8 
7 D3S1358 15 16 D3S1358 15 16 15 16 
vWA 17 18 vWA 17 18 17 18 
D16S539 11 12 D16S539 11 12 11 12 
CSF1PO 12 12 CSF1PO 12 12 12 12 
TPOX 8 8 D6S1043 12 12 12 12 
Yindel 2   Yindel 2   2   
AMEL X   AMEL X   X   
D8S1179 12 12 D8S1179 12 12 12 12 
D21S11 28 29 D21S11 28 29 28 29 
D18S51 12 14 D18S51 12 14 12 14 
DYS391 10 10 D5S818 12 12 12 12 
D2S441 12 12 D2S441 12 12 12 12 
D19S433 13 15.2 D19S433 13 15.2 13 15.2 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
FGA 21 21 D10S1248 14 14 14 14 
D22S1045 11 17 D22S1045 11 17 11 17 
D5S818 12 12 D1S1656 12 16 12 16 
D13S317 11 13 D13S317 11 13 11 13 
D7S820 10 11 D7S820 10 11 10 11 
SE33 27.2 28.2 Penta E 7 7 7 7 
 D10S1248 14 14 Penta D 8 12 8 12 
 D1S1656 12 16 TH01 6 8 6 8 
 D12S391 19 21 D12S391 19 21 19 21 
 D2S1338 21 22 D2S1338 21 22 21 22 
       TPOX 8 8 8 8 
 D3S1358 15 16 D3S1358 15 16 15 16 
 vWA 16 18 vWA 16 18 16 18 
 D16S539 9 11 D16S539 9 11 9 11 
 CSF1PO 11 12 CSF1PO 11 12 11 12 
 TPOX 8 11 D6S1043 11 11 11 11 
8 Yindel     Yindel         
 AMEL X X AMEL x x X x 
 D8S1179 16 17 D8S1179 16 17 16 17 
 D21S11 32.2 32.2 D21S11 32.2 32.2 32.2 32.2 
 D18S51 14 15 D18S51 14 15 14 15 
 DYS391     D5S818 11 12 11 12  
D2S441 14 14 D2S441 14 14 14 14 
D19S433 13 14 D19S433 13 14 13 14 
TH01 6 7 FGA 20 21 20 21 
FGA 20 21 D10S1248 14 15 14 15 
D22S1045 15 15 D22S1045 15 15 15 15 
D5S818 11 12 D1S1656 15 16 15 16 
D13S317 11 11 D13S317 11 11 11 11 
D7S820 10 10 D7S820 10 10 10 10 
SE33 14 29.2 Penta E 13 13 13 13 
D10S1248 14 15 Penta D 11 11 11 11 
D1S1656 15 16 TH01 6 7 6 7 
D12S391 20 20 D12S391 20 20 20 20 
D2S1338 19 23 D2S1338 19 23 19 23 
      TPOX 8 11 8 11 
9 D3S1358 15 17 D3S1358 15 17 15 17 
vWA 18 19 vWA 18 19 18 19 
D16S539 11 13 D16S539 11 13 11 13 
CSF1PO 11 12 CSF1PO 11 12 11 12 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
Yindel 2   Yindel 2   2   
AMEL X Y AMEL X Y X Y 
D8S1179 13 14 D8S1179 13 14 13 14 
D21S11 30 34.2 D21S11 30 34.2 30 34.2 
D18S51 12 14 D18S51 12 14 12 14 
DYS391 11   D5S818 11 13 11 13 
 D2S441 11 14 D2S441 11 14 11 14 
 D19S433 12 16.2 D19S433 12 16.2 12 16.2 
 TH01 6 7 FGA 24 24 24 24 
 FGA 24 24 D10S1248 15 15 15 15 
 D22S1045 15 15 D22S1045 15 15 15 15 
 D5S818 11 13 D1S1656 15 17 15 17 
 D13S317 11 12 D13S317 11 12 11 12 
 D7S820 8 10 D7S820 8 10 8 10 
 SE33 27.2 33 Penta E 7 14 7 14 
 D10S1248 15 15 Penta D 12 13 12 13 
 D1S1656 15 17 TH01 6 7 6 7 
 D12S391 15 22 D12S391 15 22 15 22 
 D2S1338 18 24 D2S1338 18 24 18 24 
       TPOX 8 9 8 9 
10 D3S1358 16 17 D3S1358 16 17 16 17 
 vWA 13 14 vWA 13 14 13 14 
 D16S539 9 11 D16S539 9 11 9 11 
 CSF1PO 11 12 CSF1PO 11 12 11 12  
TPOX 8 11 D6S1043 11 13 11 13 
Yindel 2   Yindel 2   2   
AMEL X Y AMEL X Y X Y 
D8S1179 13 14 D8S1179 13 14 13 14 
D21S11 27 30 D21S11 27 30 27 30 
D18S51 15 19 D18S51 15 19 15 19 
DYS391 10   D5S818 12 12 12 12 
D2S441 11 14 D2S441 11 14 11 14 
D19S433 15 15.2 D19S433 15 15.2 15 15.2 
TH01 7 9 FGA 21 23 21 23 
FGA 21 23 D10S1248 14 14 14 14 
D22S1045 14 15 D22S1045 14 15 14 15 
D5S818 12 12 D1S1656 11 11 11 11 
D13S317 12 12 D13S317 12 12 12 12 
D7S820 10 11 D7S820 10 11 10 11 
SE33 17 35.2 Penta E 17 18 17 18 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
D1S1656 11 11 TH01 7 9 7 9 
D12S391 22 24 D12S391 22 24 22 24 
D2S1338 17 17 D2S1338 17 17 17 17 
      TPOX 8 11 8 11 
11 D3S1358 15 17 D3S1358 15 17 15 17 
vWA 17 18 vWA 17 18 17 18 
 D16S539 11 12 D16S539 11 12 11 12 
 CSF1PO 10 12 CSF1PO 10 12 10 12 
 TPOX 8 9 D6S1043 12 17 12 17 
 Yindel 2   Yindel 2   2   
 AMEL X Y AMEL X Y X Y 
 D8S1179 13 14 D8S1179 13 14 13 14 
 D21S11 29 31 D21S11 29 31 29 31 
 D18S51 13 18 D18S51 13 18 13 18 
 DYS391 10   D5S818 12 13 12 13 
 D2S441 11 14 D2S441 11 14 11 14 
 D19S433 14 14.2 D19S433 14 14.2 14 14.2 
 TH01 9 9 FGA 21 26 21 26 
 FGA 21 26 D10S1248 13 15 13 15 
 D22S1045 16 16 D22S1045 16 16 16 16 
 D5S818 12 13 D1S1656 16 16.3 16 16.3 
 D13S317 13 13 D13S317 13 13 13 13 
 D7S820 10 10 D7S820 10 10 10 10 
 SE33 17 20 Penta E 17 18 17 18 
 D10S1248 13 15 Penta D 9 14 9 14 
 D1S1656 16 16.3 TH01 9 9 9 9  
D12S391 22 22 D12S391 22 22 22 22 
D2S1338 20 21 D2S1338 20 22 20 22 
      TPOX 8 9 8 9 
12 D3S1358 16 18 D3S1358 16 18 16 18 
vWA 15 16 vWA 15 16 15 16 
D16S539 12 12 D16S539 12 12 12 12 
CSF1PO 5 11 CSF1PO 5 11 5 11 
TPOX 8 9 D6S1043 12 19 12 19 
Yindel 2   Yindel 2   2   
AMEL X Y AMEL X Y X Y 
D8S1179 14 14 D8S1179 14 14 14 14 
D21S11 29 31 D21S11 29 31 29 31 
D18S51 13 15 D18S51 13 15 13 15 
DYS391 11   D5S818 9 12 9 12 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
D19S433 13 14 D19S433 13 14 13 14 
TH01 6 9 FGA 23 24 23 24 
FGA 23 24 D10S1248 15 16 15 16 
D22S1045 15 15 D22S1045 15 15 15 15 
D5S818 9 12 D1S1656 15.3 16 15.3 16 
D13S317 8 11 D13S317 8 11 8 11 
 D7S820 9 11 D7S820 9 11 9 11 
 SE33 14 17 Penta E 11 13 11 13 
 D10S1248 15 16 Penta D 9 15 9 15 
 D1S1656 15.3 16 TH01 6 9 6 9 
 D12S391 18 24 D12S391 18 24 18 24 
 D2S1338 16 20 D2S1338 16 20 16 20 
       TPOX 8 9 8 9 
 D1S1656 15.3 16 TH01 6 9 6 9 
 D12S391 18 24 D12S391 18 24 18 24 
 D2S1338 16 20 D2S1338 16 20 16 20 
       TPOX 8 9 8 9 
13 D3S1358 15 18 D3S1358 15 18 15 18 
 vWA 16 16 vWA 16 16 16 16 
 D16S539 10 12 D16S539 10 12 10 12 
 CSF1PO 11 11 CSF1PO 11 11 11 11 
 TPOX 9 10 D6S1043 11 12 11 12 
 Yindel 2   Yindel 2   2   
 AMEL X Y AMEL X Y X Y 
 D8S1179 14 16 D8S1179 14 16 14 16 
 D21S11 28 30 D21S11 28 30 28 30 
 D18S51 14 16 D18S51 14 16 14 16 
 DYS391 10   D5S818 10 12 10 12 
 D2S441 14 14 D2S441 14 14 14 14 
 D19S433 12 13.2 D19S433 12 13.2 12 13.2 
 TH01 9 9 FGA 21 24 21 24 
 FGA 21 24 D10S1248 14 15 14 15  
D22S1045 15 16 D22S1045 15 16 15 16 
D5S818 10 12 D1S1656 11 11 11 11 
D13S317 11 11 D13S317 11 11 11 11 
D7S820 11 13 D7S820 11 13 11 13 
SE33 30.2 31.2 Penta E 9 12 9 12 
D10S1248 14 15 Penta D 12 12 12 12 
D1S1656 11 11 TH01 9 9 9 9 
D12S391 24 26 D12S391 24 26 24 26 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
      TPOX 9 10 9 10 
14 D3S1358 16 17 D3S1358 16 17 16 17 
vWA 15 16 vWA 15 16 15 16 
D16S539 11 14 D16S539 11 14 11 14 
CSF1PO 11 13 CSF1PO 11 13 11 13 
TPOX 9 9 D6S1043 11 14 11 14 
 Yindel     Yindel         
 AMEL X X AMEL X X X X 
 D8S1179 10 13 D8S1179 10 13 10 13 
 D21S11 30 32.2 D21S11 30 32.2 30 32.2 
 D18S51 13 18 D18S51 13 18 13 18 
 DYS391     D5S818 11 11 11 11 
 D2S441 11 14 D2S441 11 14 11 14 
 D19S433 13 15 D19S433 13 15 13 15 
 TH01 6 9 FGA 22 24 22 24 
 FGA 22 24 D10S1248 14 14 14 14 
 D22S1045 11 12 D22S1045 11 12 11 12 
 D5S818 11 11 D1S1656 12 16 12 16 
 D13S317 10 12 D13S317 10 12 10 12 
 D7S820 9 11 D7S820 9 11 9 11 
 SE33 27.2 32.2 Penta E 11 12 11 12 
 D10S1248 14 14 Penta D 13 14 13 14 
 D1S1656 12 16 TH01 6 9 6 9 
 D12S391 20 21 D12S391 20 21 20 21 
 D2S1338 20 21 D2S1338 20 21 20 21 
       TPOX 9 9 9 9 
15 D3S1358 15 16 D3S1358 15 16 15 16 
 vWA 16 16 vWA 16 16 16 16 
 D16S539 11 11 D16S539 11 11 11 11 
 CSF1PO 12 12 CSF1PO 12 12 12 12 
 TPOX 8 8 D6S1043 19 19 19 19 
 Yindel     Yindel         
 AMEL X X AMEL X X X X 
 D8S1179 10 12 D8S1179 10 12 10 12  
D21S11 31 31.2 D21S11 31 31.2 31 31.2 
D18S51 16 16 D18S51 16 16 16 16 
DYS391     D5S818 11 12 11 12 
D2S441 11 15 D2S441 11 15 11 15 
D19S433 13 13 D19S433 13 13 13 13 
TH01 6 9 FGA 22 25 22 25 






Table 16: Concordance study with blood and buccal swab samples using GlobalFiler 
(GF) and Verifiler Plus (VFP) PCR kits (continued)   
Sample markers GF markers VFP- Blood VFP- Buccal swab 
 
D22S1045 11 16 D22S1045 11 16 11 16 
D5S818 11 12 D1S1656 13 14.2 13 14.2 
D13S317 11 12 D13S317 11 12 11 12 
D7S820 8 12 D7S820 8 12 8 12 
SE33 17 22 Penta E 11 20 11 20 
D10S1248 13 16 Penta D 10 12 10 12 
 D1S1656 13 OL TH01 6 9 6 9 
 D12S391 17 20 D12S391 17 20 17 20 
 D2S1338 17 23 D2S1338 17 23 17 23 
       TPOX 8 8 8 8 
16 D3S1358 15 18 D3S1358 15 18 15 18  
vWA 14 16 vWA 14 16 14 16 
D16S539 12 12 D16S539 12 12 12 12 
CSF1PO 10 12 CSF1PO 10 12 10 12 
TPOX 9 10 D6S1043 13 14 13 14 
Yindel 2   Yindel 2   2   
AMEL X Y AMEL X Y X Y 
D8S1179 12 13 D8S1179 12 13 12 13 
D21S11 28 29 D21S11 28 29 28 29 
D18S51 12 14 D18S51 12 14 12 14 
DYS391 10   D5S818 11 12 11 12 
D2S441 11 14 D2S441 11 14 11 14 
D19S433 13 15 D19S433 13 15 13 15 
TH01 7 9 FGA 20 25 20 25 
FGA 20 25 D10S1248 14 15 14 15 
D22S1045 15 15 D22S1045 15 15 15 15 
D5S818 11 12 D1S1656 13 16.3 13 16.3 
D13S317 8 10 D13S317 8 10 8 10 
D7S820 11 11 D7S820 11 11 11 11 
SE33 15 18 Penta E 12 20 12 20 
D10S1248 14 15 Penta D 2.2 9 2.2 9 
D1S1656 13 16.3 TH01 7 9 7 9 
D12S391 21 24 D12S391 21 24 21 24 
D2S1338 17 19 D2S1338 17 19 17 19 
      TPOX 9 10 9 10 
Note: Markers in red represent the difference between the two PCR kits. 
